We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

CRISPR is a powerful gene-editing tool that holds enormous potential for treating genetic diseases by allowing scientists to ...

Distilled water is a completely different animal than regular drinking water, and it can be important to have on hand.

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

EU-backed researchers and doctors are pioneering advanced pre-implantation and prenatal genetic testing to improve the chance ...

With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but ...

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it ...

If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...